Investor Toolbox
Read Transcript
Transcript not yet available.
View Infographic
Infographic not yet available.
REGN Coverage
Event
Regeneron Pharmaceuticals Inc (REGN) BofA Securities Health Care Conference 2026
Apr 20, 2026
Event
Regeneron Pharmaceuticals Inc (REGN) Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)
Apr 13, 2026
Event
Regeneron Pharmaceuticals Inc (REGN) Sec Form 8K
Apr 9, 2026
Transcript
Regeneron Pharmaceuticals Inc (REGN) Q4 2025 Earnings Call Transcript
Feb 2, 2026
Transcript
Regeneron Pharmaceuticals Inc (REGN) Q2 2025 Earnings Call Transcript
Jan 22, 2026
Transcript
Regeneron Pharmaceuticals Inc (REGN) Q3 2025 Earnings Call Transcript
Jan 22, 2026
News
Earnings: Regeneron Pharmaceuticals (REGN) Q1 profit falls; revenue up 7%
May 4, 2023
Press Release
Earnings: Regeneron Pharmaceuticals (REGN) Q4 profit falls as revenues drop 31%
Feb 3, 2023